4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Recruiting now · Phase 1/Phase 2

Conditions studied: Neovascular (Wet) Age-Related Macular Degeneration

In brief

Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will evaluate the safety and tolerability of 4D-150 contralateral eye dosing and characterize vector shedding.

Key facts

Study ID
NCT05197270
Run by
4D Molecular Therapeutics
People needed
215
Starts
2021-12-09
Expected to finish
2031-01-01
Last updated by the study team
2026-02-12

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.